Hansoh Pharmaceutical Group Co's EBIT per Share for the
six
months ended in Dec. 2025 was $0.07.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.15.
During the past 12 months, the average EBIT per Share Growth Rate of Hansoh Pharmaceutical Group Co was 41.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 24.90% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 10.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Hansoh Pharmaceutical Group Co's EBIT per Share or its related term are showing as below:
HNSPF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -3.3 Med: 11.1 Max: 24.9
Current: 24.9
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Hansoh Pharmaceutical Group Co was 24.90% per year. The lowest was -3.30% per year. And the median was 11.10% per year.
HNSPF's 3-Year EBIT Growth Rate is ranked better than 73.09% of 810
companies
in the Drug Manufacturers industry
Industry Median: 7.5
vs HNSPF: 24.90
Hansoh Pharmaceutical Group Co (OTCPK:HNSPF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Hansoh Pharmaceutical Group Co EBIT per Share Related Terms
Hansoh Pharmaceutical Group Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.15
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co (HNSPF) has a EBIT per Share of $0.15 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hansoh Pharmaceutical Group Co and its competitors. According to the industry distribution chart, Hansoh Pharmaceutical Group Co ranks #218 out of 810 companies in the Drug Manufacturers industry, placing it in the top 26.9%.
Is Hansoh Pharmaceutical Group Co's EBIT per Share too high?
Hansoh Pharmaceutical Group Co's current EBIT per Share is $0.15. The Drug Manufacturers industry median EBIT per Share is 7.50. Hansoh Pharmaceutical Group Co's value of $0.15 is 98% below this industry median. Based on the distribution chart, Hansoh Pharmaceutical Group Co ranks #218 out of 810 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hansoh Pharmaceutical Group Co has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hansoh Pharmaceutical Group Co's EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hansoh Pharmaceutical Group Co ranks #218 out of 810 companies for EBIT per Share. This puts Hansoh Pharmaceutical Group Co in the upper half of its industry. The industry median EBIT per Share is 7.50. Hansoh Pharmaceutical Group Co's value of $0.15 is 98% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.50, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hansoh Pharmaceutical Group Co's current EBIT per Share of $0.15 is 98% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hansoh Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hansoh Pharmaceutical Group Co's current EBIT per Share is $0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hansoh Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co (HNSPF) is currently considered Fairly Valued. The stock's GF Value™ is $3.64, compared to a current price of $3.83 — trading 5.1% above its estimated fair value. The current EBIT per Share is $0.15 and 98% below the Drug Manufacturers industry median of 7.50. Hansoh Pharmaceutical Group Co's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Hansoh Pharmaceutical Group Co (HNSPF), the current EBIT per Share is $0.15 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hansoh Pharmaceutical Group Co (HNSPF) Overvalued in 2026?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co stock appears to be overvalued.
The current stock price of $3.83 is trading 5.1% above its estimated GF Value™ of $3.64.
GuruFocus considers Hansoh Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for HNSPF:
EBIT per Share: $0.15
GF Value™: $3.64 vs. price of $3.83 (5.1% above fair value)
Industry Position: 98% below the Drug Manufacturers median (#218 of 810)
No single metric tells the full story. See the HNSPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hansoh Pharmaceutical Group Co Business Description
Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
91GF Score
Get the complete analysis for HNSPF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HNSPF has been successfully added to your 
